Thus, for vitiligo, extreme genetic risk and early disease onset are genetically associated with a MHC class II haplotype that is associated with increased HLA-DQ expression, rather than with specific HLA alleles that produce structurally different HLA proteins. The gene discussed is HLA-C; the disease is vitiligo.